Showing 39,941 - 39,960 results of 134,360 for search '(( 2 we decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.29s Refine Results
  1. 39941

    Novel DNA Aptamer for CYP24A1 Inhibition with Enhanced Antiproliferative Activity in Cancer Cells by Madhu Biyani (12427332)

    Published 2022
    “…One of the identified aptamers, Apt-7, showed a 5.8-fold higher binding affinity with CYP24 than the similar competitor CYP27B1. …”
  2. 39942

    FLIM FRET efficiency of: (A) αA-crystallin (B) WT αB-crystallin, their deamidated and domain mutants. by Ekta Tiwary (836674)

    Published 2015
    “…<p>FRET efficiency was calculated from the decrease in life-lime (presented in Fig 8) in 5 to 6 cells. …”
  3. 39943
  4. 39944

    Image 5_MIF tautomerase inhibitor TE-11 prevents inflammatory macrophage activation and glycolytic reprogramming while reducing leukocyte migration and improving Crohn’s disease-li... by Eszter Vámos (11081587)

    Published 2025
    “…Leukocyte recruitment, M1 macrophage polarization and associated metabolic reprogramming are hallmarks of its pathomechanism. Here, we tested TE-11, a potent MIF tautomerase inhibitor (IC<sub>50</sub> = 5.63 μmol/dm<sup>3</sup>) in experimental Crohn’s disease in male mice, in leukocyte recruitment and in inflammatory M1 macrophage activation.…”
  5. 39945

    A Distorted Cubic Tetranuclear Copper(II) Phosphonate Cage with a Double-Four-Ring-Type Core by Vadapalli Chandrasekhar (815391)

    Published 2008
    “…The reaction of Cu<sub>2</sub>(O<sub>2</sub>CMe)<sub>4</sub>·2H<sub>2</sub>O with <i>tert</i>-butylphosphonic acid and 3,5-di-<i>tert</i>-butylpyrazole in the presence of triethylamine leads to a high-yield synthesis of the tetranuclear compound [Cu<sub>2</sub>(3,5-<i>t</i>-Bu<sub>2</sub>PzH)<sub>2</sub>(<i>t</i>-BuPO<sub>3</sub>)<sub>2</sub>]<sub>2</sub> (<b>1</b>). …”
  6. 39946

    Presentation_2_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

    Published 2023
    “…</p>Results<p>Globally, in 2019 there were 488.9 million (95% UI: 457.6 to 522.6) incident cases and 2.4 million (2.3–2.7) deaths due to LRIs. The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”
  7. 39947

    Table_2_Global burden of lower respiratory infections during the last three decades.DOC by Saeid Safiri (3713035)

    Published 2023
    “…</p>Results<p>Globally, in 2019 there were 488.9 million (95% UI: 457.6 to 522.6) incident cases and 2.4 million (2.3–2.7) deaths due to LRIs. The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”
  8. 39948

    Image_2_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

    Published 2023
    “…</p>Results<p>Globally, in 2019 there were 488.9 million (95% UI: 457.6 to 522.6) incident cases and 2.4 million (2.3–2.7) deaths due to LRIs. The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”
  9. 39949
  10. 39950

    Implantation of a Berlin Heart EXCOR by Monroe McKay (17019630)

    Published 2023
    “…The anastomosis of the graft to the aorta was performed using 5-0 polypropylene in a running continuous fashion. …”
  11. 39951

    Data Sheet 5_The novel pleuromutilin derivative 22–((4-((4-nitrophenyl)acetamido)phenyl)thio)deoxy pleuromutilin possesses robust anti-mycoplasma activity both in vitro and in vivo... by Xirui Xia (12075476)

    Published 2024
    “…</p>Results<p>The results show that compound 16C has low toxicity (LD<sub>50</sub> > 5,000 mg/kg). Its pharmacokinetic profile is characterized by a short time to maximum concentration (Tmax = 0.24 h), high bioavailability (F = 71.29%), and short elimination half-life (T<sub>1/2kel</sub>) (intramuscular and intravenous administration was 2.20 and 1.89 h, respectively). …”
  12. 39952

    MdFDIA: A Mass Defect Based Four-Plex Data-Independent Acquisition Strategy for Proteome Quantification by Yi Di (4445635)

    Published 2017
    “…To alleviate this challenge, we present a mass defect based four-plex data-independent acquisition strategy, termed “MdFDIA”, for parallel analysis of four different protein samples in a DIA experiment without the additional complexity of tandem mass spectrometry (MS<sup>2</sup>) spectra. …”
  13. 39953
  14. 39954

    Image_5_CAGE Binds to Beclin1, Regulates Autophagic Flux and CAGE-Derived Peptide Confers Sensitivity to Anti-cancer Drugs in Non-small Cell Lung Cancer Cells.JPEG by Minjeong Yeon (6064790)

    Published 2018
    “…AQTGTGKT peptide restored expression levels of miR-143-3p and miR-373-5p, decreased autophagic flux and conferred sensitivity to anti-cancer drugs. …”
  15. 39955

    Table_3_Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/β-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats.docx by Xiaoya Li (2022250)

    Published 2020
    “…In vitro experiments showed that EZP combined with MTX could also improve the expression of genes related to the Wnt1/LRP5/β-catenin pathway. This study demonstrated that EZP in combination with MTX played a synergistic role in regulating OBs in RA, which was connected to the modulatory effect of EZP and MTX on the Wnt1/LRP5/β-catenin signaling pathway.…”
  16. 39956

    Table_1_Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/β-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats.docx by Xiaoya Li (2022250)

    Published 2020
    “…In vitro experiments showed that EZP combined with MTX could also improve the expression of genes related to the Wnt1/LRP5/β-catenin pathway. This study demonstrated that EZP in combination with MTX played a synergistic role in regulating OBs in RA, which was connected to the modulatory effect of EZP and MTX on the Wnt1/LRP5/β-catenin signaling pathway.…”
  17. 39957

    Table_6_Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/β-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats.docx by Xiaoya Li (2022250)

    Published 2020
    “…In vitro experiments showed that EZP combined with MTX could also improve the expression of genes related to the Wnt1/LRP5/β-catenin pathway. This study demonstrated that EZP in combination with MTX played a synergistic role in regulating OBs in RA, which was connected to the modulatory effect of EZP and MTX on the Wnt1/LRP5/β-catenin signaling pathway.…”
  18. 39958

    Table_4_Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/β-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats.docx by Xiaoya Li (2022250)

    Published 2020
    “…In vitro experiments showed that EZP combined with MTX could also improve the expression of genes related to the Wnt1/LRP5/β-catenin pathway. This study demonstrated that EZP in combination with MTX played a synergistic role in regulating OBs in RA, which was connected to the modulatory effect of EZP and MTX on the Wnt1/LRP5/β-catenin signaling pathway.…”
  19. 39959

    Table_2_Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/β-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats.docx by Xiaoya Li (2022250)

    Published 2020
    “…In vitro experiments showed that EZP combined with MTX could also improve the expression of genes related to the Wnt1/LRP5/β-catenin pathway. This study demonstrated that EZP in combination with MTX played a synergistic role in regulating OBs in RA, which was connected to the modulatory effect of EZP and MTX on the Wnt1/LRP5/β-catenin signaling pathway.…”
  20. 39960